Certara Expands Biosimulation Market with AI-Driven QSP Platform

Core Insights - Certara, Inc. has launched Certara IQ, an AI-powered Quantitative Systems Pharmacology (QSP) solution aimed at enhancing R&D productivity and reducing risks in drug development [1][3] Company Overview - Certara is a leader in model-informed drug development, providing proprietary biosimulation software and services to over 2,400 clients, including biopharmaceutical companies and regulatory agencies across 70 countries [4] Industry Trends - QSP has become essential in modern drug discovery, with FDA submissions based on QSP nearly doubling every 1.4 years since 2013, indicating a growing reliance on computational modeling in drug development [2] Product Features - Certara IQ enhances model reproducibility and reusability through an intuitive, generative-AI supported interface for building and visualizing QSP models [5] - The solution accelerates model creation with a repository of scientifically validated and pre-built QSP models, workflows, and report templates [5] - Certara IQ features a high-performance simulation engine that significantly reduces computational bottlenecks, running simulations thousands of times faster than traditional tools [5] - It empowers decision-making with a no-code interface for "what-if" analysis, allowing for quick assessments of feasibility, data gaps, and optimization of dosing and drug properties [5]